Cite
MLA Citation
J.Z. Shan et al.. “137P Tislelizumab combined with chemotherapy as neoadjuvant therapy for stage IIIA-IIIB(N2) potentially resectable squamous non-small-cell lung cancer (TACT).” Immuno-oncology technology, vol. 16, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100172068968.0x00000b